Patents by Inventor Yuji Wang

Yuji Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12003633
    Abstract: Disclosed are apparatuses, systems, and techniques to perform and facilitate secure ladder computational operations whose iterative execution depends on secret values associated with input data. Disclosed embodiments balance execution of various iterations in a way that is balanced for different secret values, significantly reducing vulnerability of ladder computations to adversarial side-channel attacks.
    Type: Grant
    Filed: March 29, 2022
    Date of Patent: June 4, 2024
    Assignee: Nvidia Corporation
    Inventors: Shuai Wang, Chen Yao, Xiao Wu, Rongzhe Zhu, Yuji Qian, Kun Yang, Weiping Pan, Xixi Xie
  • Patent number: 11985221
    Abstract: Disclosed are apparatuses, systems, and techniques to perform and facilitate secure ladder computational operations whose iterative execution depends on secret values associated with input data. Disclosed embodiments use masking factors that re-blind secret data without exposing the unmasked secret data between iterations of the ladder computations. Some disclosed embodiments use Montgomery multiplication techniques to facilitate secret data masking by efficiently avoiding modular division operations. Disclosed embodiments significantly reduce the vulnerability of ladder computations to adversarial side-channel attacks.
    Type: Grant
    Filed: March 29, 2022
    Date of Patent: May 14, 2024
    Assignee: NVIDIA Corporation
    Inventors: Shuai Wang, Chen Yao, Xiao Wu, Rongzhe Zhu, Yuji Qian, Kun Yang, Xixi Xie
  • Patent number: 11954487
    Abstract: Disclosed are apparatuses, systems, and techniques to perform and facilitate fast and efficient modular computational operations, such as modular division and modular inversion, using shared platforms, including hardware accelerator engines.
    Type: Grant
    Filed: March 29, 2022
    Date of Patent: April 9, 2024
    Assignee: Nvidia Corporation
    Inventors: Shuai Wang, Chen Yao, Xiao Wu, Rongzhe Zhu, Yuji Qian, Xixi Xie
  • Publication number: 20230270889
    Abstract: The present disclosure provides a fluorescently-traceable amino acid derivative and a preparation method and use thereof, and belongs to the technical field of biomedicine. In the present disclosure, an amino acid skeleton of the amino acid derivative is modified mainly by a fluorescently-traceable functional group. 4-chloro-7-nitro-2,1,3-benzoxadiazole (NBD-Cl) has low polarity and strong fluorescence, and can be used to modify an N-terminal of the amino acid skeleton to conduct subcellular imaging. Moreover, the NBD-Cl has a relatively small volume, lacks reaction orthogonality, and causes little interference with biochemical reactions of the organism itself. The results of examples show that the fluorescently-traceable amino acid derivative has a desirable biological activity and can be fluorescently traced in vivo and in vitro.
    Type: Application
    Filed: August 3, 2021
    Publication date: August 31, 2023
    Applicant: Capital Medical University
    Inventors: Yuji Wang, Yanming Wang, Di Zhu, Yu Lu, Botao Liu, Aijuan Qu, Hao Wu
  • Patent number: 11117866
    Abstract: The present invention discloses a terpinenol compound as well as its preparation method and application. The structure of such terpinenol compound is as shown in Formula (I) or (II). In Formula (I), R is independently selected from C12-C16 alkyl, —NR1R2, —SR3 or —OR4; R1, R2, R3 and R4 are independently selected from C1-C6 alkyl or —NO2; the C1-C6 alkyl can be substituted by OH; Alternatively, the R1 and R2 form a five-member ring or six-member ring in together with N used to link up them; the five-member or six-member ring may contain one O or C?O. As indicated by results of activity test, such terpinenol compound has satisfactory effect in prevention of asthma, inflammation and pulmonary artery hypertension, which also has high pharmaceutical significance.
    Type: Grant
    Filed: January 16, 2017
    Date of Patent: September 14, 2021
    Assignee: ZHEJIANG ACADEMY OF TRADITIONAL CHINESE MEDICINE
    Inventors: Wanping Zhu, Yongzhou Hu, Xia Liu, Fanzhi Kong, Yuji Wang
  • Patent number: 10970884
    Abstract: Systems, methods, and non-transitory computer-readable media can obtain a media item. The media item is positioned in a content item. A plurality of histograms are generated based on colors of a first portion and a second portion of the media item. A custom background for the media item in the content item is generated based on the plurality of histograms.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: April 6, 2021
    Assignee: Facebook, Inc.
    Inventors: Hongji Yang, Yuji Wang, Yuan Liang, Dan Zhang, Ren Lu, Amber Muck, Ethan Lubka, Yi-Wei Wu, Lingfei He, Yin Kam Hung, Michael Thomas Gofron
  • Publication number: 20190337900
    Abstract: The present invention discloses a terpinenol compound as well as its preparation method and application. The structure of such terpinenol compound is as shown in Formula (I) or (II). In Formula (I), R is independently selected from C12-C16 alkyl, —NR1R2, —SR3 or —OR4; R1, R2, R3 and R4 are independently selected from C1-C6 alkyl or —NO2; the C1-C6 alkyl can be substituted by OH; Alternatively, the R1 and R2 form a five-member ring or six-member ring in together with N used to link up them; the five-member or six-member ring may contain one O or C?O. As indicated by results of activity test, such terpinenol compound has satisfactory effect in prevention of asthma, inflammation and pulmonary artery hypertension, which also has high pharmaceutical significance.
    Type: Application
    Filed: January 16, 2017
    Publication date: November 7, 2019
    Applicant: ZHEJIANG ACADEMY OF TRADITIONAL CHINESE MEDICINE
    Inventors: WANPING ZHU, YONGZHOU HU, XIA LIU, FANZHI KONG, YUJI WANG
  • Patent number: 10344035
    Abstract: Disclosed is a salt of a quinoline derivative, polymorphic forms thereof, preparation methods thereof, a composition, and applications. The SPH1772 ditartrate or crystal form A thereof expresses the following excellent properties: high stability, great bioavailability, excellent pharmacokinetic properties, and better in vivo efficacy than SPH1772 free base.
    Type: Grant
    Filed: December 29, 2016
    Date of Patent: July 9, 2019
    Assignee: Shanghai Phaarmaceuticals Holding Co., Ltd.
    Inventors: Jianxin Yu, Yu Hao, Jing Zhang, Fei Zhao, Leduo Zhang, Zhenying Liu, Gongsheng Li, Yuji Wang, Na Chen, Rui Bai, Yi Fan
  • Publication number: 20190010160
    Abstract: Disclosed is a salt of a quinoline derivative, polymorphic forms thereof, preparation methods thereof, a composition, and applications. The SPH1772 ditartrate or crystal form A thereof expresses the following excellent properties: high stability, great bioavailability, excellent pharmacokinetic properties, and better in vivo efficacy than SPH1772 free base.
    Type: Application
    Filed: December 29, 2016
    Publication date: January 10, 2019
    Inventors: Jianxin YU, Yu HAO, Jing ZHANG, Fei ZHAO, Leduo ZHANG, Zhenying LIU, Gongsheng LI, Yuji WANG, Na CHEN, Rui BAI, Yi FAN
  • Patent number: 8969333
    Abstract: PAD4 inhibitory compositions and methods for their use in treatment of cancer and autoimmune disease are provided according to embodiments of the present invention.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: March 3, 2015
    Assignee: The Penn State Research Foundation
    Inventors: Gong Chen, Yanming Wang, Pingxin Li, Jing Hu, Shu Wang, Yuji Wang
  • Publication number: 20140288059
    Abstract: PAD4 inhibitory compositions and methods for their use in treatment of cancer and autoimmune disease are provided according to embodiments of the present invention.
    Type: Application
    Filed: April 25, 2014
    Publication date: September 25, 2014
    Applicant: THE PENN STATE RESEARCH FOUNDATION
    Inventors: Gong Chen, Yanming Wang, Pingxin Li, Jing Hu, Shu Wang, Yuji Wang
  • Patent number: 8710039
    Abstract: PAD4 inhibitory compositions and methods for their use in treatment of cancer and autoimmune disease are provided according to embodiments of the present invention.
    Type: Grant
    Filed: November 1, 2011
    Date of Patent: April 29, 2014
    Assignee: The Penn State Research Foundation
    Inventors: Gong Chen, Yanming Wang, Pingxin Li, Jing Hu, Shu Wang, Yuji Wang
  • Publication number: 20120108562
    Abstract: PAD4 inhibitory compositions and methods for their use in treatment of cancer and autoimmune disease are provided according to embodiments of the present invention.
    Type: Application
    Filed: November 1, 2011
    Publication date: May 3, 2012
    Applicant: The Penn State Research Foundation
    Inventors: Gong Chen, Yanming Wang, Pingxin Li, Jing Hu, Shu Wang, Yuji Wang